Nye behandlinger til patienter med hjertestop

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Nye behandlinger til patienter med hjertestop. / Rudolph, Søren Steemann; Isbye, Dan Lou; Pfeiffer, Peter; Kjærgaard, Jesper.

In: Ugeskrift for Laeger, Vol. 180, V05170386, 2018.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rudolph, SS, Isbye, DL, Pfeiffer, P & Kjærgaard, J 2018, 'Nye behandlinger til patienter med hjertestop', Ugeskrift for Laeger, vol. 180, V05170386. <http://ugeskriftet.dk/videnskab/nye-behandlinger-til-patienter-med-hjertestop>

APA

Rudolph, S. S., Isbye, D. L., Pfeiffer, P., & Kjærgaard, J. (2018). Nye behandlinger til patienter med hjertestop. Ugeskrift for Laeger, 180, [V05170386]. http://ugeskriftet.dk/videnskab/nye-behandlinger-til-patienter-med-hjertestop

Vancouver

Rudolph SS, Isbye DL, Pfeiffer P, Kjærgaard J. Nye behandlinger til patienter med hjertestop. Ugeskrift for Laeger. 2018;180. V05170386.

Author

Rudolph, Søren Steemann ; Isbye, Dan Lou ; Pfeiffer, Peter ; Kjærgaard, Jesper. / Nye behandlinger til patienter med hjertestop. In: Ugeskrift for Laeger. 2018 ; Vol. 180.

Bibtex

@article{b74b16016aa943ae8ccf981d3aeda22e,
title = "Nye behandlinger til patienter med hjertestop",
abstract = "In an advanced emergency medical service all parts of the advanced life support (ALS) algorithm can be provided. This evidence-based algorithm outlines resuscitative efforts for the first 10-15 minutes after cardiac arrest, whereafter the algorithm repeats itself. Restoration of spontaneous circulation fails in most cases, but in some circumstances the patient may benefit from additional interventional approaches, in which case transport to hospital with ongoing cardiopulmonary resuscitation is indicated. This paper has summarized treatments outside the ALS algorithm, which may be beneficial, but are not supported by firm scientific evidence.",
keywords = "Adrenal Cortex Hormones/therapeutic use, Adrenergic beta-1 Receptor Antagonists/therapeutic use, Advanced Cardiac Life Support/methods, Algorithms, Cardiopulmonary Resuscitation/methods, Electric Countershock/methods, Extracorporeal Membrane Oxygenation, Heart Arrest/drug therapy, Humans, Methylene Blue/therapeutic use, Percutaneous Coronary Intervention, Propanolamines/therapeutic use, Vasoconstrictor Agents/therapeutic use",
author = "Rudolph, {S{\o}ren Steemann} and Isbye, {Dan Lou} and Peter Pfeiffer and Jesper Kj{\ae}rgaard",
year = "2018",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",

}

RIS

TY - JOUR

T1 - Nye behandlinger til patienter med hjertestop

AU - Rudolph, Søren Steemann

AU - Isbye, Dan Lou

AU - Pfeiffer, Peter

AU - Kjærgaard, Jesper

PY - 2018

Y1 - 2018

N2 - In an advanced emergency medical service all parts of the advanced life support (ALS) algorithm can be provided. This evidence-based algorithm outlines resuscitative efforts for the first 10-15 minutes after cardiac arrest, whereafter the algorithm repeats itself. Restoration of spontaneous circulation fails in most cases, but in some circumstances the patient may benefit from additional interventional approaches, in which case transport to hospital with ongoing cardiopulmonary resuscitation is indicated. This paper has summarized treatments outside the ALS algorithm, which may be beneficial, but are not supported by firm scientific evidence.

AB - In an advanced emergency medical service all parts of the advanced life support (ALS) algorithm can be provided. This evidence-based algorithm outlines resuscitative efforts for the first 10-15 minutes after cardiac arrest, whereafter the algorithm repeats itself. Restoration of spontaneous circulation fails in most cases, but in some circumstances the patient may benefit from additional interventional approaches, in which case transport to hospital with ongoing cardiopulmonary resuscitation is indicated. This paper has summarized treatments outside the ALS algorithm, which may be beneficial, but are not supported by firm scientific evidence.

KW - Adrenal Cortex Hormones/therapeutic use

KW - Adrenergic beta-1 Receptor Antagonists/therapeutic use

KW - Advanced Cardiac Life Support/methods

KW - Algorithms

KW - Cardiopulmonary Resuscitation/methods

KW - Electric Countershock/methods

KW - Extracorporeal Membrane Oxygenation

KW - Heart Arrest/drug therapy

KW - Humans

KW - Methylene Blue/therapeutic use

KW - Percutaneous Coronary Intervention

KW - Propanolamines/therapeutic use

KW - Vasoconstrictor Agents/therapeutic use

M3 - Tidsskriftartikel

C2 - 29393026

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V05170386

ER -

ID: 215864459